In a world where overmedication is becoming an increasingly concerning issue, especially among the elderly, the concept of 'deprescribing' has emerged as a crucial topic for healthcare professionals and researchers alike. This article delves into the complexities and potential benefits of deprescribing, offering a comprehensive analysis and personal insights into this fascinating yet challenging practice.
The Overmedication Crisis
To set the scene, let's consider the startling statistic: a significant portion of Italians over 65 are taking upwards of 20 medications daily. This raises an immediate question: are we truly caring for these individuals, or simply prescribing more and more drugs without a clear understanding of the potential harms?
Gianluca Trifirò, a clinical pharmacologist and professor, puts it bluntly: "Prescribing 20 medications is not care." This statement serves as a stark reminder of the potential dangers of overmedication and the need for a paradigm shift in our approach to healthcare.
Defining Deprescribing
Deprescribing, as defined by Shanna Trenaman, is a systematic process aimed at discontinuing medications when the potential harms outweigh the benefits. It's a nuanced practice, differing from treatment optimization, which focuses on ensuring the best outcomes from drug treatment.
The challenges in studying deprescribing are numerous. Researchers must consider methodological questions, such as the observation window for evaluating treatment discontinuation and the impact of individual patient factors. Trenaman highlights the importance of considering dose reductions and tapering, as these gradual approaches can also be beneficial.
The ISPE's Role
The International Society for Pharmacoepidemiology (ISPE) has recognized the importance of deprescribing and has taken significant steps to address the issue. In 2025, they published two key documents, presented by Daniela Moga, which aim to improve the methodology for assessing the effects of deprescribing in older adults.
The first document, a systematic review, identified several gaps in current methodologies, including a focus on complete discontinuation rather than gradual dose reduction and a lack of clarity around the timing of deprescribing. The second document, REMROSE-D, provides 23 recommendations to guide researchers in this field.
A Global Perspective
ISPE's research extends beyond methodology, as demonstrated by Sri Harsha Chalasani's presentation on the use of patient-reported outcomes (PROs) in deprescribing. This project, conducted across 11 countries, highlighted the importance of considering the patient's perspective and the need for empathy-based approaches.
ISPE President Ursula Kirchmayer further broadened the perspective, discussing the benefits and challenges of deprescribing for patients, healthcare providers, and health systems. The potential benefits are significant, from reducing drug interactions and adverse events to improving treatment adherence and quality of life. However, challenges exist, including building trust between patients and physicians and overcoming cultural barriers and time constraints.
Bringing Deprescribing into Practice
The journey towards integrating deprescribing into daily medical practice is a complex one. Trifirò suggests a three-pronged approach: training, organizational models, and research. He highlights the importance of dedicated services, like the one in Verona, which have achieved strong results.
Additionally, collaboration among professionals, including pharmacoepidemiologists, clinical pharmacologists, and primary care physicians, is crucial. Building trust with patients and utilizing technology to support decision-making are also key components.
Final Thoughts
Deprescribing is a fascinating yet challenging practice with the potential to revolutionize healthcare. While there are numerous obstacles to overcome, the benefits for patients, healthcare professionals, and health systems are significant. As we continue to navigate this complex issue, it's crucial to maintain a patient-centric approach and embrace the potential for positive change.
Personally, I believe that deprescribing represents a critical step towards a more holistic and effective healthcare system. It's a reminder that sometimes, less really can be more.
